Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Glioma 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Thoracic Diseases 1Sarcoma, Ewing 1Prostatic Neoplasms 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pancreatitis 1Oligodendroglioma 1Musculoskeletal Diseases 1Lymphatic Metastasis 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Hyperparathyroidism, Primary 1Hemorrhage 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Ependymoma 1Disease 1Colorectal Neoplasms 1Choledocholithiasis 1Cholangitis 1Cholangiocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 6Yoga 2Temozolomide 2Gadolinium DTPA 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1fluorodopa F 18 1alovudine 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Mind-Body Therapies 1Methotrexate 1Meditation 1Magnetic Resonance Imaging 1Etanidazole 1Early Intervention, Educational 1DNA Methylation 1Congresses as Topic 1Chemotherapy, Adjuvant 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gliosarcoma × Congresses as Topic × Clear all
NCT00430079 2013-01-16

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

National Cancer Institute (NCI)

Phase NA Terminated
48 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡